Publication date: Jun 30, 2025
Included studies involved individuals with at least 1 comorbidity: cardiovascular or cerebrovascular disease, chronic lung conditions, diabetes, or obesity. Outcomes assessed included risk of death, hospitalization, intensive care unit (ICU) admission, and composite endpoints. The results showed that 68 out of 72 studies were included in the meta-analysis. Participant counts per comorbidity ranged from 3,28,870 to 13,720,480. Data was pooled using random-effects models.
| Concepts | Keywords |
|---|---|
| Death | Ci |
| Diabetes | Comorbidities |
| June | Covid |
| Researchers | Death |
| Diabetes | |
| Disease | |
| Era | |
| Heart | |
| Hospitalization | |
| Included | |
| Individuals | |
| Omicron | |
| Outcomes | |
| Risk | |
| Risks |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | Infectious Disease |
| pathway | REACTOME | Infectious disease |
| disease | MESH | comorbidity |
| disease | MESH | cerebrovascular disease |
| disease | MESH | obesity |
| disease | MESH | death |
| disease | MESH | chronic obstructive pulmonary disease |
| disease | MESH | respiratory diseases |
| disease | MESH | heart disease |
| disease | MESH | heart failure |
Original Article
(Visited 6 times, 1 visits today)